3D Bio
2015
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$8.46M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Owner and operator of a regenerative medicine company. The company develops a 3D printing technology that can print 3D images of living tissues for surgically healing patients.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare Technology Systems
Primary Office
- 355 Lexington Avenue
- Suite 1002 (Alex Grasso, Esq.)
- New York, NY 10017
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore 3D Bio’s full profile, request a free trial.
3D Bio Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 10-Apr-2019 | $8.46M | 00.000 | Completed | Startup |
3D Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Blue Collective | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| Kairos Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
3D Bio Executive Team (6)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| James Masters | Co-Founder & Co-Chief Executive Officer | ||
| Hod Lipson | Co-Founder | ||
| Larry Bonassar | Co-Founder | ||
| Daniel Cohen Ph.D | Co-Founder & Chief Executive Officer |
2 Former Executives
You’re viewing 4 of 6 executives. Get the full list »